Hasta la próxima

Auto reproducción

EGFR+ Non–Small Cell Lung Cancer: Frontline Options

2 vistas • 07/04/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Expert Mark Socinski, MD, shares insight on the frontline systemic therapy options available for EGFR-mutant non–small cell lung cancer treatment and considers the value of multidisciplinary care in the context of brain metastases.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción